Betamethasone Sodium Phosphate + Betamethasone Dipropionate Injection Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP is a specialized Betamethasone Sodium Phosphate + Betamethasone Dipropionate Injection Manufacturer in India, delivering advanced corticosteroid injectable formulations for hospitals, clinics, and global healthcare markets. This dual-action injectable combination is widely used in the treatment of severe inflammatory disorders, allergic reactions, rheumatic conditions, musculoskeletal disorders, and corticosteroid-responsive diseases. Betamethasone Sodium Phosphate provides rapid therapeutic action, while Betamethasone Dipropionate offers prolonged anti-inflammatory activity for sustained symptom control. The formulation is developed under sterile pharmaceutical environments using high-grade active ingredients to ensure safety, efficacy, and consistent clinical performance.

As a reliable Betamethasone Injection Exporter in India, Sterile Injectable Supplier, and Contract Injectable Manufacturer, Genliva Wellness LLP supplies export-quality injectable products to regulated and semi-regulated international markets. Our manufacturing infrastructure follows stringent GMP standards and advanced injectable production protocols to support pharmaceutical distributors, healthcare institutions, and private label companies. With expertise in third party injectable manufacturing, pharmaceutical export services, and customized packaging solutions, we provide dependable corticosteroid injections for global healthcare requirements.

Betamethasone Sodium Phosphate + Betamethasone Dipropionate Injection is formulated for rapid and sustained anti-inflammatory action in various acute and chronic medical conditions.

Dual-action corticosteroid injectable formulation
Provides fast and prolonged anti-inflammatory response
Manufactured in sterile GMP-compliant facilities
High-quality formulation with reliable stability
Suitable for hospital and clinical administration
Available for export and contract manufacturing supply

This injectable formulation is widely used for the management of inflammatory, allergic, orthopedic, and corticosteroid-responsive conditions.

Treatment of severe inflammatory disorders
Management of allergic reactions and hypersensitivity conditions
Used in arthritis and musculoskeletal therapies
Effective for rheumatic and orthopedic conditions
Supports corticosteroid therapy in clinical care
Used in hospital and emergency treatment settings

The combination of Betamethasone Sodium Phosphate and Betamethasone Dipropionate provides immediate as well as long-lasting therapeutic benefits for improved treatment outcomes.

Offers rapid and sustained symptom relief
Helps reduce inflammation and allergic reactions effectively
Sterile injectable formulation with reliable performance
Supports improved patient recovery and comfort
Suitable for global pharmaceutical supply requirements
Ideal for injectable distributors and contract manufacturing businesses